Skip to content

Effect of melatonin and clonidine on postoperative delirium

Comparison of the effects of melatonin and clonidine in the prevention of postoperative delirium in patients undergoing major orthopedic surgeries

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170316033099N7
Enrollment
150
Registered
2019-03-25
Start date
2019-02-26
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium. Delirium, unspecified

Interventions

Intervention 1: Intervention group 1 (clonidine): They will receive 100 micrograms clonidine the night before surgery at bedtime and 100 micrograms 90 minutes before surgery. Intervention 2: Intervent

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients undergoing major elective orthopedic surgery Age above 65 years Informed consent for participation

Exclusion criteria

Exclusion criteria: Abbreviated mental test score below 8 Blood pressure lower than 100 millimeters of mercury History of depression that has resulted in hospitalization or use of psychiatric drugs Dementia History of head trauma causing hematoma or dementia History of tumor and cerebral infarction History of common disorders of the glands such as hyperthyroidism and hypothyroidism Chronic metabolic disorders History of head and neck radiotherapy History of poisoning with heavy metals and carbon monoxide Alcohol consumption for more than a year Chronic liver and kidney disease Presence of chronic infectious diseases Consumption of psychiatric and hypnotic drugs on a regular basis

Design outcomes

Primary

MeasureTime frame
Delirium. Timepoint: 24, 48, and 72 hours after syrgery. Method of measurement: abbreviated mental test and mini-mental state examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Amirhosain Ebrahimi

Birjand University of Medical Sciences

amirebrahimi100@gmail.com+98 56 3234 9394

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026